The growing demand for specific immunological investigation and therapeutic development has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using diverse expression systems, including bacterial hosts, animal cell cultures,